PL422415A1 - New nucleoside-diphosphate analog, pharmaceutical composition containing the nucleoside-diphosphate analog, its application and synthesis method - Google Patents

New nucleoside-diphosphate analog, pharmaceutical composition containing the nucleoside-diphosphate analog, its application and synthesis method

Info

Publication number
PL422415A1
PL422415A1 PL422415A PL42241517A PL422415A1 PL 422415 A1 PL422415 A1 PL 422415A1 PL 422415 A PL422415 A PL 422415A PL 42241517 A PL42241517 A PL 42241517A PL 422415 A1 PL422415 A1 PL 422415A1
Authority
PL
Poland
Prior art keywords
nucleoside
diphosphate analog
application
new
pharmaceutical composition
Prior art date
Application number
PL422415A
Other languages
Polish (pl)
Other versions
PL238768B1 (en
Inventor
Joanna Romanowska
Justyna Gołębiewska
Marta Rachwalak
Tomasz Jakubowski
Aleksandra Dąbrowska
Original Assignee
Instytut Chemii Bioorganicznej Polskiej Akademii Nauk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Instytut Chemii Bioorganicznej Polskiej Akademii Nauk filed Critical Instytut Chemii Bioorganicznej Polskiej Akademii Nauk
Priority to PL422415A priority Critical patent/PL238768B1/en
Publication of PL422415A1 publication Critical patent/PL422415A1/en
Publication of PL238768B1 publication Critical patent/PL238768B1/en

Links

Abstract

Przedmiotem zgłoszenia są nowe analogi nukleozydo difosforanów, ich zastosowanie jako środków przeciwwirusowych, oraz sposób otrzymywania tych związków. W szczególności zgłoszenie dotyczy siarkowych lub selenowych analogów nukleozydo 5'-difosfranów stanowiących nową grupę pochodnych nukleotydowych, oraz ich zastosowania jako leków antywirusowych, zwłaszcza hamujących namnażanie ludzkiego wirusa niedoboru odporności (HIV).The subject of the application are new nucleoside diphosphate analogues, their use as antiviral agents, and the method of obtaining these compounds. In particular, the application relates to sulfur or selenium nucleoside 5'-diphosphine analogs, a new group of nucleotide derivatives, and their use as antiviral drugs, especially those inhibiting the reproduction of human immunodeficiency virus (HIV).

PL422415A 2017-07-31 2017-07-31 New nucleoside-diphosphate analog, pharmaceutical composition containing the nucleoside-diphosphate analog, its application and synthesis method PL238768B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL422415A PL238768B1 (en) 2017-07-31 2017-07-31 New nucleoside-diphosphate analog, pharmaceutical composition containing the nucleoside-diphosphate analog, its application and synthesis method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL422415A PL238768B1 (en) 2017-07-31 2017-07-31 New nucleoside-diphosphate analog, pharmaceutical composition containing the nucleoside-diphosphate analog, its application and synthesis method

Publications (2)

Publication Number Publication Date
PL422415A1 true PL422415A1 (en) 2019-02-11
PL238768B1 PL238768B1 (en) 2021-10-04

Family

ID=65270256

Family Applications (1)

Application Number Title Priority Date Filing Date
PL422415A PL238768B1 (en) 2017-07-31 2017-07-31 New nucleoside-diphosphate analog, pharmaceutical composition containing the nucleoside-diphosphate analog, its application and synthesis method

Country Status (1)

Country Link
PL (1) PL238768B1 (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL217694B1 (en) * 2010-10-19 2014-08-29 Inst Chemii Bioorg Polskiej Akademii Nauk Nucleotide analog, process for nucleotide analog preparation, the use of the nucleotide analog, antivirus pro-nucleotide, pharmaceutical composition

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL217694B1 (en) * 2010-10-19 2014-08-29 Inst Chemii Bioorg Polskiej Akademii Nauk Nucleotide analog, process for nucleotide analog preparation, the use of the nucleotide analog, antivirus pro-nucleotide, pharmaceutical composition

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
ALEXANDRE HOFER, A MODULAR SYNTHESIS OF MODIFIED PHOSPHOANHYDRIDES, 6 July 2015 (2015-07-06) *
JOANNA ROMANOWSKA, ARYL NUCLEOSIDE H-PHOSPHONATES. PART 16: SYNTHESIS AND ANTI-HIV-1 ACTIVITY OF DI-ARYL NUCLEOSIDE PHOSPHOTRIESTERS, May 2009 (2009-05-01) *
KONRAD MISIURA I WSP., SYNTHESIS OF NUCLEOSIDE A-THIOTRIPHOSPHATES VIA AN OXATHIAPHOSPHOLANE APPROACH, July 2005 (2005-07-01) *

Also Published As

Publication number Publication date
PL238768B1 (en) 2021-10-04

Similar Documents

Publication Publication Date Title
CY1122125T1 (en) SUBSTITUTED NUCLEOSITES, NUCLEOTIDES AND THEIR ANALOGUES
DOP2018000153A (en) DERIVATIVES OF 4-AMINO-2- (1H-PIRAZOLO [3,4-B] PIRIDINA-3-IL) -6-OXO-6,7-DIHIDRO-5H-PIRROLO [2,3-D] PYRIMIDINE AND RESPECTIVES DERIVATIVES OF (1H-INDAZOL-3-IL) AS CGMP MODULATORS FOR THE TREATMENT OF CARDIOVASCULAR DISEASES
EA201890573A1 (en) NEW 6-6-BICYCLIC AROMATIC RING SUBSTITUTED NUCLEOSIDE ANALOGUES FOR APPLICATION AS PRMT5 INHIBITORS
PH12018502606A1 (en) Phosphoramidate nucleoside derivatives as anticancer agents
PH12012502284A1 (en) Antiviral nucleoside analogs
MX2017006649A (en) Triazolo-pyrazinyl derivatives useful as soluble guanylate cyclase activators.
EA201691554A1 (en) 4'-DIFFORMER DISCHARGE-DETERMINED DERIVATIVES OF NUCLEOSIDES AS AN INHIBITORS OF RNA VIRUS REPLICATION INHIBITORS
GEP20237502B (en) B-D-2'-DEOXY-2'a-FLUORO-2'-B-C-SUBSTITUTED-2-MODIFIED-N6-SUBSTITUTED PURINE NUCLEOTIDES FOR HCV TREATMENT
PH12015502588A1 (en) 4`-fluoro-2`-methyl substituted nucleoside derivatives
EA201890654A1 (en) THERAPEUTIC COMPOSITIONS FOR THE TREATMENT OF THE HUMAN IMMUNODEFICIENCY VIRUS
MX2015011779A (en) Bridged bicyclic nucleosides.
MX2022016405A (en) 1'-cyano nucleoside analogs and uses thereof.
GEP20227373B (en) Novel, highly active amino-thiazole substituted indole-2-carboxamides active against the hepatitis b virus (hbv)
CL2018000005A1 (en) Composition for oral care comprising calcium silicate.
MX2017011978A (en) Deuterated analogs of etifoxine, their derivatives and uses therof.
PH12015502589A1 (en) 4`-azido, 3`-deoxy-3`-fluoro substituted nucleoside derivatives
EA202191955A1 (en) MODIFIED RELEASE TABLET FORMULATIONS CONTAINING PHOSPHODIESTERASE INHIBITORS
MX2020008929A (en) Saturated ring-condensed dihydropyrimidinone or dihydrotriazinone compound, and pharmaceutical use thereof.
MX2021006993A (en) Cyclopentyl nucleoside analogs as anti-virals.
EA201800388A1 (en) Macroheterocyclic NUCLEOSIDE DERIVATIVES AND THEIR ANALOGUES, OBTAINING AND APPLICATION
PL422415A1 (en) New nucleoside-diphosphate analog, pharmaceutical composition containing the nucleoside-diphosphate analog, its application and synthesis method
EA202091341A1 (en) PYRAZOLOPYRIMIDINES WITH RESPIRATORY SYNCITIAL VIRUS (RSV)
WO2016123318A3 (en) Design synthesis and methods of use of acyclic fleximer nucleoside analogues having anti-coronavirus activity
MX2021009278A (en) Antiviral nucleosides and derivatives thereof.
MX2021006992A (en) Cyclobutyl nucleoside analogs as anti-virals.